Alahmar Ahmed T, Calogero Aldo E, Sengupta Pallav, Dutta Sulagna
College of Science, University of Sumer, Thi-Qar, Iraq.
University Teaching Hospital Policlinico-Vittorio Emanuele, University of Catania, Catania, Italy.
World J Mens Health. 2021 Apr;39(2):346-351. doi: 10.5534/wjmh.190145. Epub 2020 Jan 20.
Oxidative stress and sperm DNA fragmentation (SDF) are potential contributing factors for idiopathic male infertility. Coenzyme Q10 (CoQ10) have been reported to be effective in the treatment of idiopathic male infertility, in general, owing to its antioxidant properties. Thus, the present study intends to investigate the effects of CoQ10 therapy on semen parameters, oxidative stress markers and SDF in infertile men, specifically with idiopathic oligoasthenozoospermia (OA).
In this case-control study, sixty-five infertile patients with idiopathic OA and forty fertile men (control) were included. All participants underwent semen analysis based on the World Health Organization guidelines (5th edition, 2010). Patients received CoQ10 at the dose of 200 mg/d orally for three months. Seminal plasma CoQ10, total antioxidant capacity (TAC), total reactive oxygen species (ROS), glutathione peroxidase (GPx), and SDF levels were measured in controls (baseline) and infertile patients pre- and post-CoQ10 treatment.
CoQ10 treatment for three months significantly improved sperm concentration (p<0.05), progressive motility (p<0.05), total motility (p<0.01), seminal fluid CoQ10 concentration (p<0.001), TAC (p<0.001), and GPx (p<0.001) levels in infertile men with OA. Further, ROS level (p<0.05) and SDF percentage (p<0.001) were reduced in OA patients as compared to the baseline. CoQ10 levels also correlated positively with sperm concentration (r=0.48, p=0.01) and total motility (r=0.59, p=0.003) while a negative correlation was recorded between SDF and sperm motility (r=-0.54, p=0.006).
CoQ10 supplementation for three months could improve semen parameters, oxidative stress markers and reduce SDF in infertile men with idiopathic OA.
氧化应激和精子DNA碎片(SDF)是特发性男性不育的潜在促成因素。据报道,辅酶Q10(CoQ10)通常因其抗氧化特性而对特发性男性不育的治疗有效。因此,本研究旨在探讨CoQ10治疗对不育男性,特别是患有特发性少弱精子症(OA)的男性的精液参数、氧化应激标志物和SDF的影响。
在这项病例对照研究中,纳入了65例患有特发性OA的不育患者和40名有生育能力的男性(对照组)。所有参与者均根据世界卫生组织指南(第5版,2010年)进行精液分析。患者口服200mg/d的CoQ10,持续三个月。在对照组(基线)以及不育患者CoQ10治疗前后测量精浆CoQ10、总抗氧化能力(TAC)、总活性氧(ROS)、谷胱甘肽过氧化物酶(GPx)和SDF水平。
CoQ10治疗三个月显著改善了患有OA的不育男性的精子浓度(p<0.05)、前向运动率(p<0.05)、总运动率(p<0.01)、精浆CoQ10浓度(p<0.001)、TAC(p<0.001)和GPx(p<0.001)水平。此外,与基线相比,OA患者的ROS水平(p<0.05)和SDF百分比(p<0.001)降低。CoQ10水平还与精子浓度(r=0.48,p=0.01)和总运动率(r=0.59,p=0.003)呈正相关,而SDF与精子运动率之间呈负相关(r=-0.54,p=0.006)。
补充CoQ10三个月可改善患有特发性OA的不育男性的精液参数、氧化应激标志物并降低SDF。